blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1417169

EP1417169 - SELECTIVE ESTROGEN RECEPTOR MODULATORS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  03.11.2006
Database last updated on 08.10.2024
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
Bristol-Myers Squibb Pharma Company
P.O. Box 4000
Princeton NJ 08543-4000 / US
[N/P]
Former [2004/20]For all designated states
Bristol-Myers Squibb Pharma Company
PO Box 4000
Princeton, New Jesey 08543-4000 / US
Inventor(s)01 / KALTENBACH, Robert
2004 Walmsley Drive
Wilmington, DE 19808 / US
02 / ROBINSON, Simon
P.O. Box 497
Stow, MA 01775 / US
03 / TRAINOR, George
9 Carillon Court
Wilmington, DE 19803 / US
 [2004/20]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2004/20]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date02757058.909.08.2002
[2004/20]
WO2002US25394
Priority number, dateUS20010311466P11.08.2001         Original published format: US 311466 P
[2004/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03016270
Date:27.02.2003
Language:EN
[2003/09]
Type: A2 Application without search report 
No.:EP1417169
Date:12.05.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 27.02.2003 takes the place of the publication of the European patent application.
[2004/20]
Search report(s)International search report - published on:EP06.11.2003
ClassificationIPC:C07C311/51, C07C69/587, C07C69/653, C07C57/48, C07C31/10, C07D311/58, C07D257/04, A61P19/10, A61P9/00, A61P13/00, A61P35/00, A61K31/192, A61K31/18, A61K31/352, A61K31/41
[2004/20]
CPC:
C07D257/04 (EP,US); A61P1/00 (EP); A61P13/00 (EP);
A61P13/08 (EP); A61P15/00 (EP); A61P19/10 (EP);
A61P25/28 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P5/30 (EP); A61P9/00 (EP);
C07C255/34 (EP,US); C07C311/51 (EP,US); C07C51/487 (EP,US);
C07C57/50 (EP,US); C07C59/54 (EP,US); C07C59/72 (EP,US);
C07C69/618 (EP,US); C07C69/734 (EP,US); C07D277/80 (EP,US);
C07D311/58 (EP,US); C07D333/34 (EP,US); C07C2601/10 (EP,US);
C07C2602/10 (EP,US); C07C2602/12 (EP,US) (-)
C-Set:
C07C51/487, C07C59/54 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/20]
Extension statesAL09.03.2004
LT09.03.2004
LV09.03.2004
MK09.03.2004
RO09.03.2004
SI09.03.2004
TitleGerman:SELEKTIVE ÖSTROGENREZEPTORMODULATOREN[2004/20]
English:SELECTIVE ESTROGEN RECEPTOR MODULATORS[2004/20]
French:MODULATEURS SELECTIFS DE RECEPTEUR D'OESTROGENE[2004/20]
Entry into regional phase09.03.2004National basic fee paid 
09.03.2004Designation fee(s) paid 
09.03.2004Examination fee paid 
Examination procedure24.02.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
11.02.2004Amendment by applicant (claims and/or description)
09.03.2004Examination requested  [2004/25]
18.10.2006Application withdrawn by applicant  [2006/49]
Fees paidRenewal fee
09.03.2004Renewal fee patent year 03
12.08.2005Renewal fee patent year 04
14.08.2006Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US5681835  (WILLSON TIMOTHY MARK [US]) [X] 1-3,8-11,13-17 *compounds 6, 8 and 9*; column 22, line 66 - column 23, line 9 *;
 [X]WO9908682  (UNIV DUKE [US]) [X] 1-3,8-11,13-17 *compounds GW 5638 and GW 7604*;; table I * * claim - *;
 [X]US6005003  (NIQUE FRANCOIS [FR]) [X] 1-3,7,12-17 * column 3 * * column 6, line 55 - column 7, line 52 *;
 [A]WO0126651  (ENDORECH INC [CA], et al) [A] 1-17*the whole document*;
 [PX]WO0177055  (DU PONT PHARM CO [US]) [PX] 1-3,8-11,13-17 * page 12, lines 32-35 * * page 13, lines 6-27; example -; claim - *;
 [PX]WO0177057  (DU PONT PHARM CO [US]) [PX] 1-3,8-11,13-17 *compounds of formula (I) in particular compounds 5 and 6*; page 23 - page 25; claim - *;
 [X]  - THOMAS S. SCANLAN, "Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites", CHEMISTRY & BIOLOGY, (2001), vol. 8, no. 5, pages 427 - 436, XP002220838 [X] 1-3,8-11,13-17 * abstract *

DOI:   http://dx.doi.org/10.1016/S1074-5521(01)00025-4
 [X]  - CAPLUS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 121:34956, XP002222761 [X] 1-3,8-17 * abstract *
    [ ] - TIMOTHY M. WILSON ET AL, "3-[4-(1,2-Diphenylbut-1-enyl)phenyl]acrylic Acid: A Non-Steroidal Estrogen with Functional Selectivity for Bone over Uterus in Rats", J.MED.CHEM., (1994), vol. 37, no. 11, pages 1550 - 1552, XP002091552

DOI:   http://dx.doi.org/10.1021/jm00037a002
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.